Cargando…
Thrombosis Complications in Pediatric Acute Lymphoblastic Leukemia: Risk Factors, Management, and Prevention: Is There Any Role for Pharmacologic Prophylaxis?
Pediatric acute lymphoblastic leukemia (ALL) has achieved close to 90% cure rates through extensive collaborative and integrative molecular research, clinical studies, and advances in supportive care. Despite this high achievement, venous thromboembolic complications (VTE) remain one of the most com...
Autor principal: | Rodriguez, Vilmarie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960248/ https://www.ncbi.nlm.nih.gov/pubmed/35359904 http://dx.doi.org/10.3389/fped.2022.828702 |
Ejemplares similares
-
Epigenetic Modifications in Pediatric Acute Lymphoblastic Leukemia
por: Burke, Michael J., et al.
Publicado: (2014) -
Chemotherapy-Induced Oxidative Stress in Pediatric Acute Lymphoblastic Leukemia
por: Chaudhary, Preety, et al.
Publicado: (2023) -
Assessment of the Prevalence of Infections in Pediatric Patients With Acute Lymphoblastic Leukemia
por: Nair, Arun, et al.
Publicado: (2023) -
Pediatric Leukemia From an Orthopedic Perspective: A Case of Acute Lymphoblastic Leukemia Initially Managed as Septic Hip With Osteomyelitis
por: Gkoudina, Antigoni, et al.
Publicado: (2022) -
The Role of the Central Nervous System Microenvironment in Pediatric Acute Lymphoblastic Leukemia
por: Gossai, Nathan P., et al.
Publicado: (2017)